Results 101 to 110 of about 10,636 (185)

Neuroleptic Malignant Syndrome Requiring Neurological Intensive Care Unit Follow-up: Review with Nine Cases

open access: yesTürk Yoğun Bakim Derneği Dergisi, 2014
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening clinical manifestation induced by neuroleptic medication. Although NMS is regarded as a psychiatric diagnosis, its treatment requires a systematic approach and thus intensive care follow-
Nazlı Gamze Bülbül   +4 more
doaj   +1 more source

The pharmacist’s response to the needs of patients undergoing treatment with psychotropic medication [PDF]

open access: yes, 1999
The usage of psychotropic (Table 1) medication is considerable world wide. In Malta, this can be attested to by the numerous studies that have been conducted by the University of Malta Department of Pharmacy (in conjuction with other institutions and ...
Sant Fournier, Mary Ann
core  

Neuroleptic Malignant Syndrome After the Use of Venlafaxine in a Patient with Generalized Anxiety Disorder

open access: yesJournal of the Formosan Medical Association, 2006
Neuroleptic malignant syndrome (NMS) is a potentially lethal adverse reaction to neuroleptics, which is characterized by hyperthermia, extrapyramidal symptoms, altered consciousness and autonomic dysfunction.
Tsung-Chien Lu, Wen-Jone Chen
doaj   +1 more source

Tracing diagnosis trajectories over millions of patients reveal an unexpected risk in schizophrenia. [PDF]

open access: yes, 2019
The identification of novel disease associations using big-data for patient care has had limited success. In this study, we created a longitudinal disease network of traced readmissions (disease trajectories), merging data from over 10.4 million ...
Butte, Atul J   +8 more
core  

Catatonia: extinct, lost, or forgotten? [PDF]

open access: yes
Catatonia is a neuropsychiatric syndrome that occurs in some primary psychiatric disorders (e.g., schizophrenia, mood disorders), or due to general medical conditions (e.g., neurological disorders, drug poisoning, metabolic disorders) (1).
Forouzan Elyasi*,
core  

Electroconvulsive Therapy: A Review of Its Current Status [PDF]

open access: yes, 2012
This article presents an overview of the current knowledge and practice of ECT. It provides a brief history of the development of ECT followed by a discussion of the accepted indications for ECT in psychiatric practice, including major depression ...
Certa, Kenneth   +4 more
core   +1 more source

Neuroleptic Malignant Syndrome [PDF]

open access: yesBritish Journal of Psychiatry, 1991
T K, Tan, S H, Ong
openaire   +2 more sources

Hyperthermia and postmortem biochemical investigations [PDF]

open access: yes, 2018
The postmortem diagnosis of heat-related deaths presents certain difficulties. Firstly, preterminal or terminal body temperatures are often not available.
Mangin, Patrice, Palmiere, Cristian
core  

Benzodiazepine and Opioid Withdrawal Induced Neuroleptic Malignant Like Syndrome: A Clinical Case Report With Management Complexities

open access: yesNeuropsychopharmacology Reports
Delirium may be an uncommon side effect of withdrawal from benzodiazepines and opioids. A small number of case reports illustrate the catatonia and malignant catatonia linked to withdrawal from opioids and benzodiazepines.
Behnam Abbasi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy